# Viromed Medical Places 450,000 Shares at EUR 4.50, Raising EUR 2 Million

> Viromed Medical placed 450,000 new shares at EUR 4.50 each, raising about EUR 2 million for working capital and lifting share capital to EUR 21.7 million.

- Published: 2026-10-26T17:18:13+00:00
- Section: Funding
- Author: News Desk
- URL: https://newsforagent.com/news/2026-10-26/viromed-medical-capital-increase-shares
- Source: [TradingView](https://www.tradingview.com/news/eqs:5e0fe590d094b:0-viromed-medical-ag-successful-completion-of-capital-increase/)

## Key takeaways

- Viromed Medical placed 450,000 new registered no-par value shares at EUR 4.50 each, generating gross proceeds of approximately EUR 2 million.
- The capital increase was carried out using part of the Authorized Capital 2025 and excluded shareholders' subscription rights.
- Share capital rises from EUR 21,250,000 by EUR 450,000 to EUR 21,700,000, subject to registration in the commercial register.

[Viromed Medical](https://akta.pro/company-profiles/00059i1/viromed-medical) AG completed a capital increase on October 26, 2026, placing 450,000 new registered no-par value shares at EUR 4.50 each for gross proceeds of approximately EUR 2 million. The German medical technology company said the proceeds will finance its working capital. The details were reported by [TradingView](https://www.tradingview.com/news/eqs:5e0fe590d094b:0-viromed-medical-ag-successful-completion-of-capital-increase/).

## Viromed Medical's Share Placement and Use of Proceeds

Viromed Medical said the capital increase was carried out by partially utilizing the Authorized Capital 2025 and with the exclusion of the shareholders' subscription rights. The company said the gross proceeds of approximately EUR 2 million will be used to finance its working capital.

Subject to the registration of the implementation of the capital increase in the commercial register, the share capital will increase from EUR 21,250,000 by EUR 450,000 to EUR 21,700,000. The new shares are registered no-par value shares.

Viromed Medical specializes in the development, manufacture and distribution of medical products, according to the company. Its operating business focuses on the distribution of cold plasma technology for medical applications through its wholly owned subsidiary Viromed Medical GmbH. The company has been listed on the stock exchange since October 2022 and serves customers in the DACH region and beyond.

## Viromed Medical's Funding and Revenue Records

According to akta.pro [company records](https://akta.pro/company-data), Viromed Medical has one funding round on record, a post-IPO equity round dated February 2025. The same records list revenue of €5.1 million for FY 2025 against €1.1 million for FY 2024, and net income of €0.6 million for FY 2025 against a loss of €3.1 million for FY 2024.

| Record | Figure |
| --- | --- |
| Funding rounds on record | 1 |
| Funding round | 2025-02 post IPO equity |
| Revenue, FY 2025 | €5.1 million |
| Revenue, FY 2024 | €1.1 million |
| Net income, FY 2025 | €0.6 million |
| Net result, FY 2024 | €-3.1 million |

## Insider Sales and Board Changes Before the Placement

On October 7, 2026, FinanzNachrichten.de reported that Heike Perbandt, a person closely related to Viromed Medical's board, sold 45,600 shares on Xetra on October 5, 2026 at 5.70 EUR, disclosed to EQS Distributionsservices. On September 14, 2026, FinanzNachrichten.de reported that Heike Perbandt, daughter of board member Uwe Perbandt, sold 61,000 shares at €6.10 on September 10, 2026 off-exchange under German insider trading rules. On September 7, 2026, FinanzNachrichten.de reported that Uwe Perbandt, chairman of Viromed Medical, bought 11,300 shares on XETRA on September 4, 2026 at an average price of 5.65 EUR.

## Viromed Medical's Registration Step

The share capital increase remains subject to the registration of the implementation of the capital increase in the commercial register, the company said.

## Companies in this story

- [Viromed Medical company profile](https://akta.pro/company-profiles/00059i1/viromed-medical) · website: https://viromed.de

---
News for Agent · https://newsforagent.com/llms.txt